Potassium Citrate Tablet
NDC Package 42543-406-01
Package Information
Potassium Citrate tablets is potassium citrate extended-release tablets are contraindicated:• In patients with hyperkalemia (or who have conditions predisposing them to hyperkalemia), as a further rise in serum potassium concentration may produce cardiac arrest. This formulation utilizes a tablet delivery system. Marketed by Strides Pharma Inc., this product is identified by NDC 42543-406 and is authorized under FDA application ANDA206813.
Identification & Billing
- RxCUI: 199376 - potassium citrate 5 MEQ Extended Release Oral Tablet
- RxCUI: 199376 - K+ citrate 5 MEQ Extended Release Oral Tablet
- RxCUI: 199376 - Pot citrate 5 MEQ Extended Release Oral Tablet
- RxCUI: 199376 - potassium citrate 540 MG Extended Release Oral Tablet
- RxCUI: 199381 - potassium citrate 10 MEQ Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 42543 - Strides Pharma Inc.
- 42543-406 - Potassium Citrate
- 42543-406-01 - 100 TABLET in 1 BOTTLE
- 42543-406 - Potassium Citrate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 42543-406-01 identifies a specific commercial package of 100 tablet in 1 bottle of Potassium Citrate Extended Release, a human prescription drug labeled by Strides Pharma Inc.. This tablet is formulated for oral use and contains potassium citrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Strides Pharma Inc. on November 01, 2017. The current certification is valid through December 31, 2027.
How is this Strides Pharma Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 42543040601. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.